The Journal of Urology
Volume 176, Issue 4 , Pages 1642-1647 , October 2006

Vitamins C and K3 Sensitize Human Urothelial Tumors to Gemcitabine

  • Wassim Kassouf

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Ralph Highshaw

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Gina M. Nelkin

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Colin P. Dinney

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Financial interest and/or other relationship with AstraZeneca, GlaxoSmithKline, National Cancer Institute, Canji/Schering-Plough and Abbott/Vysis.
    • ,
  • Ashish M. Kamat

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Financial interest and/or other relationship with Healthgate, Pharmacia and Abbott.
    • Corresponding Author InformationCorrespondence and requests for reprints: Departments of Urology and Cancer Biology, Unit 1373, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030 (telephone: 713-792-3250; FAX: 713-794-4824)

Received 24 September 2005

References 

  1. Jemal A , Tiwari RC , Murray T , Ghafoor A , Samuels A , Ward E , et al.   Cancer statistics, 2004 . CA Cancer J Clin . 2004;54:8
  2. Sternberg CN , Yagoda A , Scher HI , Watson RC , Geller N , Herr HW , et al.   Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse . Cancer . 1989;64:2448
  3. von der Maase H , Hansen SW , Roberts JT , Dogliotti L , Oliver T , Moore MJ , et al.   Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer (results of a large, randomized, multinational, multicenter, phase III study) . J Clin Oncol . 2000;18:3068
  4. Hussain M , Vaishampayan U , Du W , Redman B , Smith DC . Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer . J Clin Oncol . 2001;19:2527
  5. Lamm DL , Allaway M . Current trends in bladder cancer treatment . Ann Chir Gynaecol . 2000;89:234
  6. Malone WF , Kelloff GJ , Pierson H , Greenwald P . Chemoprevention of bladder cancer . Cancer . 1987;60:650
  7. Lamm DL , Riggs DR , Shriver JS , vanGilder PF , Rach JF , DeHaven JI . Megadose vitamins in bladder cancer (a double-blind clinical trial) . J Urol . 1994;151:21
  8. Taper HS , Deckers CO , Deckers-Passau LO . Increase in nuclease activity as a possible means for detecting tumor cell sensitivity to anticancer agents . Cancer . 1981;47:523
  9. Bowie AG , O’Neill LA . Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase . J Immunol . 2000;165:7180
  10. Verrax J , Cadrobbi J , Delvaux M , Jamison JM , Gilloteaux J , Summers JL , et al.   The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy . Eur J Med Chem . 2003;38:451
  11. Kassouf W , Dinney CP , Brown G , McConkey DJ , Diehl AJ , Bar-Eli M , et al.   Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of gefitinib in bladder cancer cells . Cancer Res . 2005;65:10524
  12. Mokhtar NM , el-Aaser AA , el-Bolkainy MN , Ibrahim HA , el-Din NB , Moharram NZ . Effect of soybean feeding on experimental carcinogenesis–III. Carcinogenecity of nitrite and dibutylamine in mice: a histopathological study . Eur J Cancer Clin Oncol . 1988;24:403
  13. Mirvish SS , Wallcave L , Eagen M , Shubik P . Ascorbate-nitrite reaction (possible means of blocking the formation of carcinogenic N-nitroso compounds) . Science . 1972;177:65
  14. Leung PY , Miyashita K , Young M , Tsao CS . Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines . Anticancer Res . 1993;13:475
  15. Bram S , Froussard P , Guichard M , Jasmin C , Augery Y , Sinoussi-Barre F , et al.   Vitamin C preferential toxicity for malignant melanoma cells . Nature . 1980;284:629
  16. Nutter LM , Cheng AL , Hung HL , Hsieh RK , Ngo EO , Liu TW . Menadione (spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines) . Biochem Pharmacol . 1991;41:1283
  17. Wu FY , Liao WC , Chang HM . Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays . Life Sci . 1993;52:1797
  18. Nishikawa Y , Carr BI , Wang M , Finn F , Dowd P , Zheng ZB , et al.   Growth inhibition of hepatoma cells induced by vitamin K and its analogs . J Biol Chem . 1995;270:28304
  19. Noto V , Taper HS , Jiang YH , Janssens J , Bonte J , De Loecker W . Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action . Cancer . 1989;63:901
  20. Jamison JM , Gilloteaux J , Taper HS , Calderon PB , Summers JL . Autoschizis (a novel cell death) . Biochem Pharmacol . 2002;63:1773

 Supported by SPORE Developmental Research Grant 5P50CA091846-03.

PII: S0022-5347(06)01418-2

doi: 10.1016/j.juro.2006.06.042

The Journal of Urology
Volume 176, Issue 4 , Pages 1642-1647 , October 2006

Article Tools

* Image Usage & Resolution